+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Transplantation Market - Cumulative Impact of United States Tariffs 2025 - Global Forecast to 2030- Product Image
Transplantation Market - Cumulative Impact of United States Tariffs 2025 - Global Forecast to 2030- Product Image
New

Transplantation Market - Cumulative Impact of United States Tariffs 2025 - Global Forecast to 2030

  • PDF Icon

    Report

  • 188 Pages
  • May 2025
  • Region: Global, United States
  • 360iResearch™
  • ID: 6083581
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Transplantation Market grew from USD 31.09 billion in 2024 to USD 33.80 billion in 2025. It is expected to continue growing at a CAGR of 8.56%, reaching USD 50.91 billion by 2030.

The field of transplantation stands at a pivotal moment where cutting-edge science intersects with urgent clinical need. Over the past decade, advances in immunology, surgical technique, and preservation technologies have propelled organ and tissue replacement from promising research to life-saving reality. Yet despite these strides, challenges persist: donor shortages, graft rejection risks, and complex logistics continue to constrain patient access and outcomes. As healthcare priorities shift toward personalized, value-based care, decision-makers must navigate a rapidly evolving landscape. This executive summary offers a concise yet comprehensive overview of the forces reshaping the transplantation domain, shedding light on transformative trends, emerging policy impacts, and critical segmentation, regional and corporate dynamics. By distilling the most salient insights, this report equips experts and leaders with the context needed to align strategic initiatives, optimize resource allocation, and ultimately enhance patient survival and quality of life. The sections that follow outline key shifts, regulatory influences, segmentation nuances, regional performance, leading industry players, actionable recommendations, and a clear path forward for stakeholders committed to advancing transplant medicine.

Transformative Shifts Reshaping the Transplantation Landscape

A series of paradigm shifts is rewriting the rules of transplantation. First, breakthroughs in immunosuppressive regimens and biologics have substantially reduced acute rejection rates, transforming once-high-risk procedures into routine therapeutic options. Concurrently, organ preservation systems leveraging hypothermic and normothermic perfusion are extending viable windows for graft transport, enabling transcontinental sharing and reducing waitlist mortality. Meanwhile, regenerative medicine is making headway: stem cell-derived tissues and three-dimensional bioprinting are edging closer to clinical feasibility, promising eventual autologous solutions that could eliminate immunogenic barriers altogether.

Digital health innovations, including remote monitoring platforms and artificial intelligence-driven compatibility algorithms, are optimizing patient stratification and posttransplant care. Equally significant are policy initiatives aimed at harmonizing donor registries and incentivizing donation through streamlined consent frameworks. As these trends converge, the transplantation ecosystem is becoming more integrated, data-driven, and patient-centric. Recognizing and responding to these transformative shifts will be crucial for healthcare providers, payers, manufacturers, and regulatory bodies seeking to capitalize on emerging opportunities and overcome persistent obstacles.

Cumulative Impact of United States Tariffs Introduced in 2025

The introduction of a new tariff regime in 2025 has produced a cumulative impact on the transplantation supply chain and cost structures. Duties imposed on imported graft preservation devices, advanced biologic scaffolds, and critical instrumentation have translated into elevated prices for transplant centers, prompting many to reassess sourcing strategies. To mitigate these pressures, several institutions have accelerated partnerships with domestic manufacturers and invested in localized production capabilities.

Moreover, increased costs have driven the adoption of alternative materials and expedited innovation in synthetic and lab-grown substitutes. While higher sticker prices initially strained operating budgets, the tariff environment has, paradoxically, stimulated R&D efforts aimed at reducing reliance on imported inputs. Regulatory agencies have responded by fast-tracking approvals for novel graft materials and incentivizing public-private collaborations to secure supply resilience. Decision-makers must weigh these tariff-induced shifts when forecasting capital expenditures, structuring procurement contracts, and negotiating reimbursement frameworks.

Key Segmentation Insights Across Multiple Dimensions

Understanding the market requires a nuanced view of multiple intersecting dimensions. Based on Organ Type, analysis spans Heart, Intestine, Kidney, Liver, Lung, Pancreas, and Tissue. The Heart segment separates into Adult and Pediatric programs, while the Intestine category distinguishes Combined Liver-Intestine from Isolated Intestine transplants. Kidney transplants derive from Deceased Donors or Living Donors, and Liver procedures are classified as Orthotopic or Split Liver. Lung transplants fall into Double-Lung or Single-Lung, and Pancreas operations cover Pancreas After Kidney and Simultaneous Pancreas-Kidney. Tissue grafts include Blood Vessels, Cornea, and Skin.

Based on Transplantation Type, examination covers Allograft, Autograft, Isograft, and Xenograft. Allograft workstreams encompass Solid Organ and Tissue Transplants, whereas Autograft practice involves Autologous Skin and Bone Grafting. Isograft assessments focus on Identical Twin Donations, and Xenograft research includes both Bovine and Porcine Transplants.

Based on Application, focus areas consist of Cancer Treatment, Correction of Congenital Defects, Cosmetic Enhancement, and Organ Failure Treatment. The Cancer Treatment domain addresses Hematologic Disorders; Correction of Congenital Defects emphasizes Cardiac Defect repairs; Cosmetic Enhancement prioritizes Reconstructive Surgery methodologies; Organ Failure Treatment homes in on therapies for Liver Failure and Renal Failure.

Based on End User, the market serves Clinics, Hospitals, and Research Institutes. Clinics include Specialty Clinics, Hospitals divide into Private and Public facilities, and Research Institutes split between Academic Research entities and Clinical Trial sponsors.

Based on Procedure Type, options branch into Minimally Invasive Surgery and Open Surgery. Minimally Invasive approaches leverage Laparoscopic and Robotic systems, while Open Surgery comprises Complex and Major interventions.

Based on Material Type, offerings separate into Biologics and Synthetics. Biologics derive from Donor-Derived sources or Lab-Grown constructs, and Synthetics utilize materials such as Polylactic Acid and Polypropylene.

Key Regional Insights Delivering Diverse Growth Dynamics

Regional performance in transplantation reveals distinct patterns and opportunities. In the Americas, strong donor networks, advanced health infrastructure, and favorable reimbursement policies sustain high transplant volumes. The United States leads in technological adoption, exemplified by widespread use of organ perfusion systems and robust living donor programs. Canada supplements with streamlined registries and incentives that have increased donation rates.

In the Europe, Middle East & Africa region, regulatory harmonization across the European Union supports cross-border sharing, while Middle Eastern countries invest heavily in transplant tourism and infrastructure development. African nations, though still grappling with resource constraints, are gradually expanding capacity through targeted partnerships and mobile transplant units.

In Asia-Pacific, rising healthcare spending and rapidly growing patient populations are driving unprecedented demand. Countries such as Japan, South Korea, and Australia showcase high volumes coupled with innovative research in xenotransplantation and regenerative therapies. Meanwhile, emerging markets in Southeast Asia and India focus on scaling living donor programs and improving cold chain logistics to address organ scarcity.

Key Company Insights Shaping Competitive Advantage

The competitive landscape features established pharma and biotech giants alongside specialized solution providers. AbbVie Inc. and Sanofi S.A. are advancing immunomodulatory therapies tailored to reduce chronic rejection, while Novartis AG invests in cellular engineering platforms designed to induce tolerance. Teva Pharmaceutical Industries Ltd. exploits its manufacturing scale to deliver generic immunosuppressants at competitive price points.

Device and biologics specialists such as Stryker Corporation and Zimmer Biomet are pioneering perfusion and preservation hardware that extend graft viability. Arthrex, Inc. focuses on minimally invasive instrumentation for laparoscopic transplant procedures, while Dr. Franz Kohler Chemie GmbH supplies tissue-preservation solutions across European markets. BioLife Solutions Inc. and Terumo Corporation lead in cold storage media and transport logistics, bolstered by distribution partnerships in key hubs.

Innovative service providers also play a critical role. Mid-America Transplant and Australian Red Cross Lifeblood coordinate donor networks and allocation systems, optimizing matching algorithms and ethical frameworks. LifeCell International Pvt. Ltd. and Veloxis Pharmaceuticals are forging new paths in regenerative scaffolds and next-generation immunosuppressants. TransMedics, Inc. introduces ex-vivo organ care systems that dynamically perfuse organs to maximize function, setting a new standard in organ viability and utilization.

Actionable Recommendations for Industry Leaders

Leaders must adopt a multi-pronged approach to stay ahead. First, forging strategic alliances between biotech innovators and transplant centers will accelerate clinical translation of regenerative therapies and xenografts. Second, investing in advanced preservation technologies and cold chain optimization can buffer against supply chain disruptions and tariff pressures. Third, prioritizing data integration across registries, EMRs, and monitoring platforms will strengthen patient stratification and outcome tracking.

Furthermore, proactive engagement with policymakers to shape favorable reimbursement and donation incentives is essential. Cultivating public trust through transparent reporting and outcome-based metrics can boost donor participation and broader community support. Lastly, embedding sustainability principles into procurement and waste management practices can improve operational efficiency and align with emerging environmental standards.

Conclusion

In summary, the transplantation field is experiencing transformative shifts driven by scientific breakthroughs, policy reforms, and evolving market dynamics. Tariff-induced cost pressures have catalyzed domestic innovation, while segmentation analysis underscores the vast complexity of organ types, procedural approaches, and end users. Regional insights reveal both mature markets and high-growth corridors, each with unique regulatory and infrastructure considerations. Concurrently, leading companies are differentiating through immunomodulation, preservation hardware, and regenerative platforms.

To thrive in this environment, stakeholders must embrace collaborative R&D models, invest in supply chain resilience, and harness data-driven decision frameworks. By integrating these elements, the industry can deliver improved patient outcomes, optimize resource utilization, and ensure sustainable growth. The path forward demands agility, strategic foresight, and unwavering commitment to advancing transplant medicine.

Market Segmentation & Coverage

This research report categorizes the Transplantation Market to forecast the revenues and analyze trends in each of the following sub-segmentations:

  • Heart
    • Adult
    • Pediatric
  • Intestine
    • Combined Liver-Intestine
    • Isolated Intestine
  • Kidney
    • Deceased Donor
    • Living Donor
  • Liver
    • Orthotopic
    • Split Liver
  • Lung
    • Double-Lung
    • Single-Lung
  • Pancreas
    • Pancreas After Kidney
    • Simultaneous Pancreas-Kidney
  • Tissue
    • Blood Vessels
    • Cornea
    • Skin
  • Allograft
    • Solid Organ
    • Tissue Transplant
  • Autograft
    • Autologous Skin
    • Bone Grafting
  • Isograft
    • Identical Twin Donation
  • Xenograft
    • Bovine Transplants
    • Porcine Transplants
  • Cancer Treatment
    • Hematologic Disorders
  • Correction of Congenital Defects
    • Cardiac Defects
  • Cosmetic Enhancement
    • Reconstructive Surgery
  • Organ Failure Treatment
    • Liver Failure
    • Renal Failure
  • Clinics
    • Specialty Clinics
  • Hospitals
    • Private
    • Public
  • Research Institutes
    • Academic Research
    • Clinical Trials
  • Minimally Invasive Surgery
    • Laparoscopic
    • Robotic
  • Open Surgery
    • Complex
    • Major
  • Biologics
    • Donor Derived
    • Lab Grown
  • Synthetics
    • Polylactic Acid
    • Polypropylene

This research report categorizes the Transplantation Market to forecast the revenues and analyze trends in each of the following sub-regions:

  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Europe, Middle East & Africa
    • Denmark
    • Egypt
    • Finland
    • France
    • Germany
    • Israel
    • Italy
    • Netherlands
    • Nigeria
    • Norway
    • Poland
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom

This research report categorizes the Transplantation Market to delves into recent significant developments and analyze trends in each of the following companies:

  • AbbVie Inc.
  • Arthrex, Inc.
  • Australian Red Cross Lifeblood
  • BioLife Solutions Inc.
  • Dr. Franz Kohler Chemie GmbH
  • LifeCell International Pvt. Ltd.
  • Mid-America Transplant
  • Novartis AG
  • Sanofi S.A.
  • Stryker Corporation
  • Terumo Corporation
  • Teva Pharmaceutical Industries Ltd
  • TransMedics, Inc.
  • Veloxis Pharmaceuticals
  • Zimmer Biomet

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Transplantation Market, by Organ Type
8.1. Introduction
8.2. Heart
8.2.1. Adult
8.2.2. Pediatric
8.3. Intestine
8.3.1. Combined Liver-Intestine
8.3.2. Isolated Intestine
8.4. Kidney
8.4.1. Deceased Donor
8.4.2. Living Donor
8.5. Liver
8.5.1. Orthotopic
8.5.2. Split Liver
8.6. Lung
8.6.1. Double-Lung
8.6.2. Single-Lung
8.7. Pancreas
8.7.1. Pancreas After Kidney
8.7.2. Simultaneous Pancreas-Kidney
8.8. Tissue
8.8.1. Blood Vessels
8.8.2. Cornea
8.8.3. Skin
9. Transplantation Market, by Transplantation Type
9.1. Introduction
9.2. Allograft
9.2.1. Solid Organ
9.2.2. Tissue Transplant
9.3. Autograft
9.3.1. Autologous Skin
9.3.2. Bone Grafting
9.4. Isograft
9.4.1. Identical Twin Donation
9.5. Xenograft
9.5.1. Bovine Transplants
9.5.2. Porcine Transplants
10. Transplantation Market, by Application
10.1. Introduction
10.2. Cancer Treatment
10.2.1. Hematologic Disorders
10.3. Correction of Congenital Defects
10.3.1. Cardiac Defects
10.4. Cosmetic Enhancement
10.4.1. Reconstructive Surgery
10.5. Organ Failure Treatment
10.5.1. Liver Failure
10.5.2. Renal Failure
11. Transplantation Market, by End User
11.1. Introduction
11.2. Clinics
11.2.1. Specialty Clinics
11.3. Hospitals
11.3.1. Private
11.3.2. Public
11.4. Research Institutes
11.4.1. Academic Research
11.4.2. Clinical Trials
12. Transplantation Market, by Procedure Type
12.1. Introduction
12.2. Minimally Invasive Surgery
12.2.1. Laparoscopic
12.2.2. Robotic
12.3. Open Surgery
12.3.1. Complex
12.3.2. Major
13. Transplantation Market, by Material Type
13.1. Introduction
13.2. Biologics
13.2.1. Donor Derived
13.2.2. Lab Grown
13.3. Synthetics
13.3.1. Polylactic Acid
13.3.2. Polypropylene
14. Americas Transplantation Market
14.1. Introduction
14.2. Argentina
14.3. Brazil
14.4. Canada
14.5. Mexico
14.6. United States
15. Asia-Pacific Transplantation Market
15.1. Introduction
15.2. Australia
15.3. China
15.4. India
15.5. Indonesia
15.6. Japan
15.7. Malaysia
15.8. Philippines
15.9. Singapore
15.10. South Korea
15.11. Taiwan
15.12. Thailand
15.13. Vietnam
16. Europe, Middle East & Africa Transplantation Market
16.1. Introduction
16.2. Denmark
16.3. Egypt
16.4. Finland
16.5. France
16.6. Germany
16.7. Israel
16.8. Italy
16.9. Netherlands
16.10. Nigeria
16.11. Norway
16.12. Poland
16.13. Qatar
16.14. Russia
16.15. Saudi Arabia
16.16. South Africa
16.17. Spain
16.18. Sweden
16.19. Switzerland
16.20. Turkey
16.21. United Arab Emirates
16.22. United Kingdom
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. AbbVie Inc.
17.3.2. Arthrex, Inc.
17.3.3. Australian Red Cross Lifeblood
17.3.4. BioLife Solutions Inc.
17.3.5. Dr. Franz Kohler Chemie GmbH
17.3.6. LifeCell International Pvt. Ltd.
17.3.7. Mid-America Transplant
17.3.8. Novartis AG
17.3.9. Sanofi S.A.
17.3.10. Stryker Corporation
17.3.11. Terumo Corporation
17.3.12. Teva Pharmaceutical Industries Ltd
17.3.13. TransMedics, Inc.
17.3.14. Veloxis Pharmaceuticals
17.3.15. Zimmer Biomet
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. TRANSPLANTATION MARKET MULTI-CURRENCY
FIGURE 2. TRANSPLANTATION MARKET MULTI-LANGUAGE
FIGURE 3. TRANSPLANTATION MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL TRANSPLANTATION MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL TRANSPLANTATION MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL TRANSPLANTATION MARKET SIZE, BY ORGAN TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL TRANSPLANTATION MARKET SIZE, BY ORGAN TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL TRANSPLANTATION MARKET SIZE, BY TRANSPLANTATION TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL TRANSPLANTATION MARKET SIZE, BY TRANSPLANTATION TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL TRANSPLANTATION MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL TRANSPLANTATION MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL TRANSPLANTATION MARKET SIZE, BY PROCEDURE TYPE, 2024 VS 2030 (%)
FIGURE 16. GLOBAL TRANSPLANTATION MARKET SIZE, BY PROCEDURE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL TRANSPLANTATION MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2030 (%)
FIGURE 18. GLOBAL TRANSPLANTATION MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES TRANSPLANTATION MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES TRANSPLANTATION MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. EUROPE, MIDDLE EAST & AFRICA TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. EUROPE, MIDDLE EAST & AFRICA TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. TRANSPLANTATION MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. TRANSPLANTATION MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. TRANSPLANTATION MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL TRANSPLANTATION MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL TRANSPLANTATION MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL TRANSPLANTATION MARKET SIZE, BY ORGAN TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL TRANSPLANTATION MARKET SIZE, BY HEART, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL TRANSPLANTATION MARKET SIZE, BY ADULT, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL TRANSPLANTATION MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL TRANSPLANTATION MARKET SIZE, BY HEART, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL TRANSPLANTATION MARKET SIZE, BY INTESTINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL TRANSPLANTATION MARKET SIZE, BY COMBINED LIVER-INTESTINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL TRANSPLANTATION MARKET SIZE, BY ISOLATED INTESTINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL TRANSPLANTATION MARKET SIZE, BY INTESTINE, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL TRANSPLANTATION MARKET SIZE, BY KIDNEY, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL TRANSPLANTATION MARKET SIZE, BY DECEASED DONOR, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL TRANSPLANTATION MARKET SIZE, BY LIVING DONOR, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL TRANSPLANTATION MARKET SIZE, BY KIDNEY, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL TRANSPLANTATION MARKET SIZE, BY LIVER, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL TRANSPLANTATION MARKET SIZE, BY ORTHOTOPIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL TRANSPLANTATION MARKET SIZE, BY SPLIT LIVER, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL TRANSPLANTATION MARKET SIZE, BY LIVER, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL TRANSPLANTATION MARKET SIZE, BY LUNG, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL TRANSPLANTATION MARKET SIZE, BY DOUBLE-LUNG, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL TRANSPLANTATION MARKET SIZE, BY SINGLE-LUNG, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL TRANSPLANTATION MARKET SIZE, BY LUNG, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL TRANSPLANTATION MARKET SIZE, BY PANCREAS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL TRANSPLANTATION MARKET SIZE, BY PANCREAS AFTER KIDNEY, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL TRANSPLANTATION MARKET SIZE, BY SIMULTANEOUS PANCREAS-KIDNEY, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL TRANSPLANTATION MARKET SIZE, BY PANCREAS, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL TRANSPLANTATION MARKET SIZE, BY TISSUE, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL TRANSPLANTATION MARKET SIZE, BY BLOOD VESSELS, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL TRANSPLANTATION MARKET SIZE, BY CORNEA, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL TRANSPLANTATION MARKET SIZE, BY SKIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL TRANSPLANTATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL TRANSPLANTATION MARKET SIZE, BY TRANSPLANTATION TYPE, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL TRANSPLANTATION MARKET SIZE, BY ALLOGRAFT, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL TRANSPLANTATION MARKET SIZE, BY SOLID ORGAN, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL TRANSPLANTATION MARKET SIZE, BY TISSUE TRANSPLANT, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL TRANSPLANTATION MARKET SIZE, BY ALLOGRAFT, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL TRANSPLANTATION MARKET SIZE, BY AUTOGRAFT, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL TRANSPLANTATION MARKET SIZE, BY AUTOLOGOUS SKIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL TRANSPLANTATION MARKET SIZE, BY BONE GRAFTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL TRANSPLANTATION MARKET SIZE, BY AUTOGRAFT, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL TRANSPLANTATION MARKET SIZE, BY ISOGRAFT, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL TRANSPLANTATION MARKET SIZE, BY IDENTICAL TWIN DONATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL TRANSPLANTATION MARKET SIZE, BY ISOGRAFT, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL TRANSPLANTATION MARKET SIZE, BY XENOGRAFT, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL TRANSPLANTATION MARKET SIZE, BY BOVINE TRANSPLANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL TRANSPLANTATION MARKET SIZE, BY PORCINE TRANSPLANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL TRANSPLANTATION MARKET SIZE, BY XENOGRAFT, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL TRANSPLANTATION MARKET SIZE, BY CANCER TREATMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL TRANSPLANTATION MARKET SIZE, BY HEMATOLOGIC DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL TRANSPLANTATION MARKET SIZE, BY CANCER TREATMENT, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL TRANSPLANTATION MARKET SIZE, BY CORRECTION OF CONGENITAL DEFECTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL TRANSPLANTATION MARKET SIZE, BY CARDIAC DEFECTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL TRANSPLANTATION MARKET SIZE, BY CORRECTION OF CONGENITAL DEFECTS, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL TRANSPLANTATION MARKET SIZE, BY COSMETIC ENHANCEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL TRANSPLANTATION MARKET SIZE, BY RECONSTRUCTIVE SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL TRANSPLANTATION MARKET SIZE, BY COSMETIC ENHANCEMENT, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL TRANSPLANTATION MARKET SIZE, BY ORGAN FAILURE TREATMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL TRANSPLANTATION MARKET SIZE, BY LIVER FAILURE, BY REGION, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL TRANSPLANTATION MARKET SIZE, BY RENAL FAILURE, BY REGION, 2018-2030 (USD MILLION)
TABLE 65. GLOBAL TRANSPLANTATION MARKET SIZE, BY ORGAN FAILURE TREATMENT, 2018-2030 (USD MILLION)
TABLE 66. GLOBAL TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 67. GLOBAL TRANSPLANTATION MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 68. GLOBAL TRANSPLANTATION MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 69. GLOBAL TRANSPLANTATION MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 70. GLOBAL TRANSPLANTATION MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 71. GLOBAL TRANSPLANTATION MARKET SIZE, BY PRIVATE, BY REGION, 2018-2030 (USD MILLION)
TABLE 72. GLOBAL TRANSPLANTATION MARKET SIZE, BY PUBLIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 73. GLOBAL TRANSPLANTATION MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 74. GLOBAL TRANSPLANTATION MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 75. GLOBAL TRANSPLANTATION MARKET SIZE, BY ACADEMIC RESEARCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 76. GLOBAL TRANSPLANTATION MARKET SIZE, BY CLINICAL TRIALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 77. GLOBAL TRANSPLANTATION MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 78. GLOBAL TRANSPLANTATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 79. GLOBAL TRANSPLANTATION MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 80. GLOBAL TRANSPLANTATION MARKET SIZE, BY LAPAROSCOPIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 81. GLOBAL TRANSPLANTATION MARKET SIZE, BY ROBOTIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 82. GLOBAL TRANSPLANTATION MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
TABLE 83. GLOBAL TRANSPLANTATION MARKET SIZE, BY OPEN SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 84. GLOBAL TRANSPLANTATION MARKET SIZE, BY COMPLEX, BY REGION, 2018-2030 (USD MILLION)
TABLE 85. GLOBAL TRANSPLANTATION MARKET SIZE, BY MAJOR, BY REGION, 2018-2030 (USD MILLION)
TABLE 86. GLOBAL TRANSPLANTATION MARKET SIZE, BY OPEN SURGERY, 2018-2030 (USD MILLION)
TABLE 87. GLOBAL TRANSPLANTATION MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 88. GLOBAL TRANSPLANTATION MARKET SIZE, BY BIOLOGICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 89. GLOBAL TRANSPLANTATION MARKET SIZE, BY DONOR DERIVED, BY REGION, 2018-2030 (USD MILLION)
TABLE 90. GLOBAL TRANSPLANTATION MARKET SIZE, BY LAB GROWN, BY REGION, 2018-2030 (USD MILLION)
TABLE 91. GLOBAL TRANSPLANTATION MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 92. GLOBAL TRANSPLANTATION MARKET SIZE, BY SYNTHETICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 93. GLOBAL TRANSPLANTATION MARKET SIZE, BY POLYLACTIC ACID, BY REGION, 2018-2030 (USD MILLION)
TABLE 94. GLOBAL TRANSPLANTATION MARKET SIZE, BY POLYPROPYLENE, BY REGION, 2018-2030 (USD MILLION)
TABLE 95. GLOBAL TRANSPLANTATION MARKET SIZE, BY SYNTHETICS, 2018-2030 (USD MILLION)
TABLE 96. AMERICAS TRANSPLANTATION MARKET SIZE, BY ORGAN TYPE, 2018-2030 (USD MILLION)
TABLE 97. AMERICAS TRANSPLANTATION MARKET SIZE, BY HEART, 2018-2030 (USD MILLION)
TABLE 98. AMERICAS TRANSPLANTATION MARKET SIZE, BY INTESTINE, 2018-2030 (USD MILLION)
TABLE 99. AMERICAS TRANSPLANTATION MARKET SIZE, BY KIDNEY, 2018-2030 (USD MILLION)
TABLE 100. AMERICAS TRANSPLANTATION MARKET SIZE, BY LIVER, 2018-2030 (USD MILLION)
TABLE 101. AMERICAS TRANSPLANTATION MARKET SIZE, BY LUNG, 2018-2030 (USD MILLION)
TABLE 102. AMERICAS TRANSPLANTATION MARKET SIZE, BY PANCREAS, 2018-2030 (USD MILLION)
TABLE 103. AMERICAS TRANSPLANTATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
TABLE 104. AMERICAS TRANSPLANTATION MARKET SIZE, BY TRANSPLANTATION TYPE, 2018-2030 (USD MILLION)
TABLE 105. AMERICAS TRANSPLANTATION MARKET SIZE, BY ALLOGRAFT, 2018-2030 (USD MILLION)
TABLE 106. AMERICAS TRANSPLANTATION MARKET SIZE, BY AUTOGRAFT, 2018-2030 (USD MILLION)
TABLE 107. AMERICAS TRANSPLANTATION MARKET SIZE, BY ISOGRAFT, 2018-2030 (USD MILLION)
TABLE 108. AMERICAS TRANSPLANTATION MARKET SIZE, BY XENOGRAFT, 2018-2030 (USD MILLION)
TABLE 109. AMERICAS TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 110. AMERICAS TRANSPLANTATION MARKET SIZE, BY CANCER TREATMENT, 2018-2030 (USD MILLION)
TABLE 111. AMERICAS TRANSPLANTATION MARKET SIZE, BY CORRECTION OF CONGENITAL DEFECTS, 2018-2030 (USD MILLION)
TABLE 112. AMERICAS TRANSPLANTATION MARKET SIZE, BY COSMETIC ENHANCEMENT, 2018-2030 (USD MILLION)
TABLE 113. AMERICAS TRANSPLANTATION MARKET SIZE, BY ORGAN FAILURE TREATMENT, 2018-2030 (USD MILLION)
TABLE 114. AMERICAS TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 115. AMERICAS TRANSPLANTATION MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 116. AMERICAS TRANSPLANTATION MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 117. AMERICAS TRANSPLANTATION MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 118. AMERICAS TRANSPLANTATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 119. AMERICAS TRANSPLANTATION MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
TABLE 120. AMERICAS TRANSPLANTATION MARKET SIZE, BY OPEN SURGERY, 2018-2030 (USD MILLION)
TABLE 121. AMERICAS TRANSPLANTATION MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 122. AMERICAS TRANSPLANTATION MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 123. AMERICAS TRANSPLANTATION MARKET SIZE, BY SYNTHETICS, 2018-2030 (USD MILLION)
TABLE 124. AMERICAS TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 125. ARGENTINA TRANSPLANTATION MARKET SIZE, BY ORGAN TYPE, 2018-2030 (USD MILLION)
TABLE 126. ARGENTINA TRANSPLANTATION MARKET SIZE, BY HEART, 2018-2030 (USD MILLION)
TABLE 127. ARGENTINA TRANSPLANTATION MARKET SIZE, BY INTESTINE, 2018-2030 (USD MILLION)
TABLE 128. ARGENTINA TRANSPLANTATION MARKET SIZE, BY KIDNEY, 2018-2030 (USD MILLION)
TABLE 129. ARGENTINA TRANSPLANTATION MARKET SIZE, BY LIVER, 2018-2030 (USD MILLION)
TABLE 130. ARGENTINA TRANSPLANTATION MARKET SIZE, BY LUNG, 2018-2030 (USD MILLION)
TABLE 131. ARGENTINA TRANSPLANTATION MARKET SIZE, BY PANCREAS, 2018-2030 (USD MILLION)
TABLE 132. ARGENTINA TRANSPLANTATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
TABLE 133. ARGENTINA TRANSPLANTATION MARKET SIZE, BY TRANSPLANTATION TYPE, 2018-2030 (USD MILLION)
TABLE 134. ARGENTINA TRANSPLANTATION MARKET SIZE, BY ALLOGRAFT, 2018-2030 (USD MILLION)
TABLE 135. ARGENTINA TRANSPLANTATION MARKET SIZE, BY AUTOGRAFT, 2018-2030 (USD MILLION)
TABLE 136. ARGENTINA TRANSPLANTATION MARKET SIZE, BY ISOGRAFT, 2018-2030 (USD MILLION)
TABLE 137. ARGENTINA TRANSPLANTATION MARKET SIZE, BY XENOGRAFT, 2018-2030 (USD MILLION)
TABLE 138. ARGENTINA TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 139. ARGENTINA TRANSPLANTATION MARKET SIZE, BY CANCER TREATMENT, 2018-2030 (USD MILLION)
TABLE 140. ARGENTINA TRANSPLANTATION MARKET SIZE, BY CORRECTION OF CONGENITAL DEFECTS, 2018-2030 (USD MILLION)
TABLE 141. ARGENTINA TRANSPLANTATION MARKET SIZE, BY COSMETIC ENHANCEMENT, 2018-2030 (USD MILLION)
TABLE 142. ARGENTINA TRANSPLANTATION MARKET SIZE, BY ORGAN FAILURE TREATMENT, 2018-2030 (USD MILLION)
TABLE 143. ARGENTINA TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 144. ARGENTINA TRANSPLANTATION MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 145. ARGENTINA TRANSPLANTATION MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 146. ARGENTINA TRANSPLANTATION MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 147. ARGENTINA TRANSPLANTATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 148. ARGENTINA TRANSPLANTATION MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
TABLE 149. ARGENTINA TRANSPLANTATION MARKET SIZE, BY OPEN SURGERY, 2018-2030 (USD MILLION)
TABLE 150. ARGENTINA TRANSPLANTATION MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 151. ARGENTINA TRANSPLANTATION MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 152. ARGENTINA TRANSPLANTATION MARKET SIZE, BY SYNTHETICS, 2018-2030 (USD MILLION)
TABLE 153. BRAZIL TRANSPLANTATION MARKET SIZE, BY ORGAN TYPE, 2018-2030 (USD MILLION)
TABLE 154. BRAZIL TRANSPLANTATION MARKET SIZE, BY HEART, 2018-2030 (USD MILLION)
TABLE 155. BRAZIL TRANSPLANTATION MARKET SIZE, BY INTESTINE, 2018-2030 (USD MILLION)
TABLE 156. BRAZIL TRANSPLANTATION MARKET SIZE, BY KIDNEY, 2018-2030 (USD MILLION)
TABLE 157. BRAZIL TRANSPLANTATION MARKET SIZE, BY LIVER, 2018-2030 (USD MILLION)
TABLE 158. BRAZIL TRANSPLANTATION MARKET SIZE, BY LUNG, 2018-2030 (USD MILLION)
TABLE 159. BRAZIL TRANSPLANTATION MARKET SIZE, BY PANCREAS, 2018-2030 (USD MILLION)
TABLE 160. BRAZIL TRANSPLANTATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
TABLE 161. BRAZIL TRANSPLANTATION MARKET SIZE, BY TRANSPLANTATION TYPE, 2018-2030 (USD MILLION)
TABLE 162. BRAZIL TRANSPLANTATION MARKET SIZE, BY ALLOGRAFT, 2018-2030 (USD MILLION)
TABLE 163. BRAZIL TRANSPLANTATION MARKET SIZE, BY AUTOGRAFT, 2018-2030 (USD MILLION)
TABLE 164. BRAZIL TRANSPLANTATION MARKET SIZE, BY ISOGRAFT, 2018-2030 (USD MILLION)
TABLE 165. BRAZIL TRANSPLANTATION MARKET SIZE, BY XENOGRAFT, 2018-2030 (USD MILLION)
TABLE 166. BRAZIL TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 167. BRAZIL TRANSPLANTATION MARKET SIZE, BY CANCER TREATMENT, 2018-2030 (USD MILLION)
TABLE 168. BRAZIL TRANSPLANTATION MARKET SIZE, BY CORRECTION OF CONGENITAL DEFECTS, 2018-2030 (USD MILLION)
TABLE 169. BRAZIL TRANSPLANTATION MARKET SIZE, BY COSMETIC ENHANCEMENT, 2018-2030 (USD MILLION)
TABLE 170. BRAZIL TRANSPLANTATION MARKET SIZE, BY ORGAN FAILURE TREATMENT, 2018-2030 (USD MILLION)
TABLE 171. BRAZIL TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 172. BRAZIL TRANSPLANTATION MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 173. BRAZIL TRANSPLANTATION MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 174. BRAZIL TRANSPLANTATION MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 175. BRAZIL TRANSPLANTATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 176. BRAZIL TRANSPLANTATION MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
TABLE 177. BRAZIL TRANSPLANTATION MARKET SIZE, BY OPEN SURGERY, 2018-2030 (USD MILLION)
TABLE 178. BRAZIL TRANSPLANTATION MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 179. BRAZIL TRANSPLANTATION MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 180. BRAZIL TRANSPLANTATION MARKET SIZE, BY SYNTHETICS, 2018-2030 (USD MILLION)
TABLE 181. CANADA TRANSPLANTATION MARKET SIZE, BY ORGAN TYPE, 2018-2030 (USD MILLION)
TABLE 182. CANADA TRANSPLANTATION MARKET SIZE, BY HEART, 2018-2030 (USD MILLION)
TABLE 183. CANADA TRANSPLANTATION MARKET SIZE, BY INTESTINE, 2018-2030 (USD MILLION)
TABLE 184. CANADA TRANSPLANTATION MARKET SIZE, BY KIDNEY, 2018-2030 (USD MILLION)
TABLE 185. CANADA TRANSPLANTATION MARKET SIZE, BY LIVER, 2018-2030 (USD MILLION)
TABLE 186. CANADA TRANSPLANTATION MARKET SIZE, BY LUNG, 2018-2030 (USD MILLION)
TABLE 187. CANADA TRANSPLANTATION MARKET SIZE, BY PANCREAS, 2018-2030 (USD MILLION)
TABLE 188. CANADA TRANSPLANTATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
TABLE 189. CANADA TRANSPLANTATION MARKET SIZE, BY TRANSPLANTATION TYPE, 2018-2030 (USD MILLION)
TABLE 190. CANADA TRANSPLANTATION MARKET SIZE, BY ALLOGRAFT, 2018-2030 (USD MILLION)
TABLE 191. CANADA TRANSPLANTATION MARKET SIZE, BY AUTOGRAFT, 2018-2030 (USD MILLION)
TABLE 192. CANADA TRANSPLANTATION MARKET SIZE, BY ISOGRAFT, 2018-2030 (USD MILLION)
TABLE 193. CANADA TRANSPLANTATION MARKET SIZE, BY XENOGRAFT, 2018-2030 (USD MILLION)
TABLE 194. CANADA TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 195. CANADA TRANSPLANTATION MARKET SIZE, BY CANCER TREATMENT, 2018-2030 (USD MILLION)
TABLE 196. CANADA TRANSPLANTATION MARKET SIZE, BY CORRECTION OF CONGENITAL DEFECTS, 2018-2030 (USD MILLION)
TABLE 197. CANADA TRANSPLANTATION MARKET SIZE, BY COSMETIC ENHANCEMENT, 2018-2030 (USD MILLION)
TABLE 198. CANADA TRANSPLANTATION MARKET SIZE, BY ORGAN FAILURE TREATMENT, 2018-2030 (USD MILLION)
TABLE 199. CANADA TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 200. CANADA TRANSPLANTATION MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 201. CANADA TRANSPLANTATION MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 202. CANADA TRANSPLANTATION MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 203. CANADA TRANSPLANTATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 204. CANADA TRANSPLANTATION MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
TABLE 205. CANADA TRANSPLANTATION MARKET SIZE, BY OPEN SURGERY, 2018-2030 (USD MILLION)
TABLE 206. CANADA TRANSPLANTATION MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 207. CANADA TRANSPLANTATION MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 208. CANADA TRANSPLANTATION MARKET SIZE, BY SYNTHETICS, 2018-2030 (USD MILLION)
TABLE 209. MEXICO TRANSPLANTATION MARKET SIZE, BY ORGAN TYPE, 2018-2030 (USD MILLION)
TABLE 210. MEXICO TRANSPLANTATION MARKET SIZE, BY HEART, 2018-2030 (USD MILLION)
TABLE 211. MEXICO TRANSPLANTATION MARKET SIZE, BY INTESTINE, 2018-2030 (USD MILLION)
TABLE 212. MEXICO TRANSPLANTATION MARKET SIZE, BY KIDNEY, 2018-2030 (USD MILLION)
TABLE 213. MEXICO TRANSPLANTATION MARKET SIZE, BY LIVER, 2018-2030 (USD MILLION)
TABLE 214. MEXICO TRANSPLANTATION MARKET SIZE, BY LUNG, 2018-2030 (USD MILLION)
TABLE 215. MEXICO TRANSPLANTATION MARKET SIZE, BY PANCREAS, 2018-2030 (USD MILLION)
TABLE 216. MEXICO TRANSPLANTATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
TABLE 217. MEXICO TRANSPLANTATION MARKET SIZE, BY TRANSPLANTATION TYPE, 2018-2030 (USD MILLION)
TABLE 218. MEXICO TRANSPLANTATION MARKET SIZE, BY ALLOGRAFT, 2018-2030 (USD MILLION)
TABLE 219. MEXICO TRANSPLANTATION MARKET SIZE, BY AUTOGRAFT, 2018-2030 (USD MILLION)
TABLE 220. MEXICO TRANSPLANTATION MARKET SIZE, BY ISOGRAFT, 2018-2030 (USD MILLION)
TABLE 221. MEXICO TRANSPLANTATION MARKET SIZE, BY XENOGRAFT, 2018-2030 (USD MILLION)
TABLE 222. MEXICO TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 223. MEXICO TRANSPLANTATION MARKET SIZE, BY CANCER TREATMENT, 2018-2030 (USD MILLION)
TABLE 224. MEXICO TRANSPLANTATION MARKET SIZE, BY CORRECTION OF CONGENITAL DEFECTS, 2018-2030 (USD MILLION)
TABLE 225. MEXICO TRANSPLANTATION MARKET SIZE, BY COSMETIC ENHANCEMENT, 2018-2030 (USD MILLION)
TABLE 226. MEXICO TRANSPLANTATION MARKET SIZE, BY ORGAN FAILURE TREATMENT, 2018-2030 (USD MILLION)
TABLE 227. MEXICO TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 228. MEXICO TRANSPLANTATION MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 229. MEXICO TRANSPLANTATION MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 230. MEXICO TRANSPLANTATION MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 231. MEXICO TRANSPLANTATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 232. MEXICO TRANSPLANTATION MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
TABLE 233. MEXICO TRANSPLANTATION MARKET SIZE, BY OPEN SURGERY, 2018-2030 (USD MILLION)
TABLE 234. MEXICO TRANSPLANTATION MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 235. MEXICO TRANSPLANTATION MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 236. MEXICO TRANSPLANTATION MARKET SIZE, BY SYNTHETICS, 2018-2030 (USD MILLION)
TABLE 237. UNITED STATES TRANSPLANTATION MARKET SIZE, BY ORGAN TYPE, 2018-2030 (USD MILLION)
TABLE 238. UNITED STATES TRANSPLANTATION MARKET SIZE, BY HEART, 2018-2030 (USD MILLION)
TABLE 239. UNITED STATES TRANSPLANTATION MARKET SIZE, BY INTESTINE, 2018-2030 (USD MILLION)
TABLE 240. UNITED STATES TRANSPLANTATION MARKET SIZE, BY KIDNEY, 2018-2030 (USD MILLION)
TABLE 241. UNITED STATES TRANSPLANTATION MARKET SIZE, BY LIVER, 2018-2030 (USD MILLION)
TABLE 242. UNITED STATES TRANSPLANTATION MARKET SIZE, BY LUNG, 2018-2030 (USD MILLION)
TABLE 243. UNITED STATES TRANSPLANTATION MARKET SIZE, BY PANCREAS, 2018-2030 (USD MILLION)
TABLE 244. UNITED STATES TRANSPLANTATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
TABLE 245. UNITED STATES TRANSPLANTATION MARKET SIZE, BY TRANSPLANTATION TYPE, 2018-2030 (USD MILLION)
TABLE 246. UNITED STATES TRANSPLANTATION MARKET SIZE, BY ALLOGRAFT, 2018-2030 (USD MILLION)
TABLE 247. UNITED STATES TRANSPLANTATION MARKET SIZE, BY AUTOGRAFT, 2018-2030 (USD MILLION)
TABLE 248. UNITED STATES TRANSPLANTATION MARKET SIZE, BY ISOGRAFT, 2018-2030 (USD MILLION)
TABLE 249. UNITED STATES TRANSPLANTATION MARKET SIZE, BY XENOGRAFT, 2018-2030 (USD MILLION)
TABLE 250. UNITED STATES TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 251. UNITED STATES TRANSPLANTATION MARKET SIZE, BY CANCER TREATMENT, 2018-2030 (USD MILLION)
TABLE 252. UNITED STATES TRANSPLANTATION MARKET SIZE, BY CORRECTION OF CONGENITAL DEFECTS, 2018-2030 (USD MILLION)
TABLE 253. UNITED STATES TRANSPLANTATION MARKET SIZE, BY COSMETIC ENHANCEMENT, 2018-2030 (USD MILLION)
TABLE 254. UNITED STATES TRANSPLANTATION MARKET SIZE, BY ORGAN FAILURE TREATMENT, 2018-2030 (USD MILLION)
TABLE 255. UNITED STATES TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 256. UNITED STATES TRANSPLANTATION MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 257. UNITED STATES TRANSPLANTATION MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 258. UNITED STATES TRANSPLANTATION MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 259. UNITED STATES TRANSPLANTATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 260. UNITED STATES TRANSPLANTATION MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
TABLE 261. UNITED STATES TRANSPLANTATION MARKET SIZE, BY OPEN SURGERY, 2018-2030 (USD MILLION)
TABLE 262. UNITED STATES TRANSPLANTATION MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 263. UNITED STATES TRANSPLANTATION MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 264. UNITED STATES TRANSPLANTATION MARKET SIZE, BY SYNTHETICS, 2018-2030 (USD MILLION)
TABLE 265. UNITED STATES TRANSPLANTATION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 266. ASIA-PACIFIC TRANSPLANTATION MARKET SIZE, BY ORGAN TYPE, 2018-2030 (USD MILLION)
TABLE 267. ASIA-PACIFIC TRANSPLANTATION MARKET SIZE, BY HEART, 2018-2030 (USD MILLION)
TABLE 268. ASIA-PACIFIC TRANSPLANTATION MARKET SIZE, BY INTESTINE, 2018-2030 (USD MILLION)
TABLE 269. ASIA-PACIFIC TRANSPLANTATION MARKET SIZE, BY KIDNEY, 2018-2030 (USD MILLION)
TABLE 270. ASIA-PACIFIC TRANSPLANTATION MARKET SIZE, BY LIVER, 2018-2030 (USD MILLION)
TABLE 271. ASIA-PACIFIC TRANSPLANTATION MARKET SIZE, BY LUNG, 2018-2030 (USD MILLION)
TABLE 272. ASIA-PACIFIC TRANSPLANTATION MARKET SIZE, BY PANCREAS, 2018-2030 (USD MILLION)
TABLE 273. ASIA-PACIFIC TRANSPLANTATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
TABLE 274. ASIA-PACIFIC TRANSPLANTATION MARKET SIZE, BY TRANSPLANTATION TYPE, 2018-2030 (USD MILLION)
TABLE 275. ASIA-PACIFIC TRANSPLANTATION MARKET SIZE, BY ALLOGRAFT, 2018-2030 (USD MILLION)
TABLE 276. ASIA-PACIFIC TRANSPLANTATION MARKET SIZE, BY AUTOGRAFT, 2018-2030 (USD MILLION)
TABLE 277. ASIA-PACIFIC TRANSPLANTATION MARKET SIZE, BY ISOGRAFT, 2018-2030 (USD MILLION)
TABLE 278. ASIA-PACIFIC TRANSPLANTATION MARKET SIZE, BY XENOGRAFT, 2018-2030 (USD MILLION)
TABLE 279. ASIA-PACIFIC TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 280. ASIA-PACIFIC TRANSPLANTATION MARKET SIZE, BY CANCER TREATMENT, 2018-2030 (USD MILLION)
TABLE 281. ASIA-PACIFIC TRANSPLANTATION MARKET SIZE, BY CORRECTION OF CONGENITAL DEFECTS, 2018-2030 (USD MILLION)
TABLE 282. ASIA-PACIFIC TRANSPLANTATION MARKET SIZE, BY COSMETIC ENHANCEMENT, 2018-2030 (USD MILLION)
TABLE 283. ASIA-PACIFIC TRANSPLANTATION MARKET SIZE, BY ORGAN FAILURE TREATMENT, 2018-2030 (USD MILLION)
TABLE 284. ASIA-PACIFIC TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 285. ASIA-PACIFIC TRANSPLANTATION MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 286. ASIA-PACIFIC TRANSPLANTATION MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 287. ASIA-PACIFIC TRANSPLANTATION MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 288. ASIA-PACIFIC TRANSPLANTATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 289. ASIA-PACIFIC TRANSPLANTATION MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
TABLE 290. ASIA-PACIFIC TRANSPLANTATION MARKET SIZE, BY OPEN SURGERY, 2018-2030 (USD MILLION)
TABLE 291. ASIA-PACIFIC TRANSPLANTATION MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 292. ASIA-PACIFIC TRANSPLANTATION MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 293. ASIA-PACIFIC TRANSPLANTATION MARKET SIZE, BY SYNTHETICS, 2018-2030 (USD MILLION)
TABLE 294. ASIA-PACIFIC TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 295. AUSTRALIA TRANSPLANTATION MARKET SIZE, BY ORGAN TYPE, 2018-2030 (USD MILLION)
TABLE 296. AUSTRALIA TRANSPLANTATION MARKET SIZE, BY HEART, 2018-2030 (USD MILLION)
TABLE 297. AUSTRALIA TRANSPLANTATION MARKET SIZE, BY INTESTINE, 2018-2030 (USD MILLION)
TABLE 298. AUSTRALIA TRANSPLANTATION MARKET SIZE, BY KIDNEY, 2018-2030 (USD MILLION)
TABLE 299. AUSTRALIA TRANSPLANTATION MARKET SIZE, BY LIVER, 2018-2030 (USD MILLION)
TABLE 300. AUSTRALIA TRANSPLANTATION MARKET SIZE, BY LUNG, 2018-2030 (USD MILLION)
TABLE 301. AUSTRALIA TRANSPLANTATION MARKET SIZE, BY PANCREAS, 2018-2030 (USD MILLION)
TABLE 302. AUSTRALIA TRANSPLANTATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
TABLE 303. AUSTRALIA TRANSPLANTATION MARKET SIZE, BY TRANSPLANTATION TYPE, 2018-2030 (USD MILLION)
TABLE 304. AUSTRALIA TRANSPLANTATION MARKET SIZE, BY ALLOGRAFT, 2018-2030 (USD MILLION)
TABLE 305. AUSTRALIA TRANSPLANTATION MARKET SIZE, BY AUTOGRAFT, 2018-2030 (USD MILLION)
TABLE 306. AUSTRALIA TRANSPLANTATION MARKET SIZE, BY ISOGRAFT, 2018-2030 (USD MILLION)
TABLE 307. AUSTRALIA TRANSPLANTATION MARKET SIZE, BY XENOGRAFT, 2018-2030 (USD MILLION)
TABLE 308. AUSTRALIA TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 309. AUSTRALIA TRANSPLANTATION MARKET SIZE, BY CANCER TREATMENT, 2018-2030 (USD MILLION)
TABLE 310. AUSTRALIA TRANSPLANTATION MARKET SIZE, BY CORRECTION OF CONGENITAL DEFECTS, 2018-2030 (USD MILLION)
TABLE 311. AUSTRALIA TRANSPLANTATION MARKET SIZE, BY COSMETIC ENHANCEMENT, 2018-2030 (USD MILLION)
TABLE 312. AUSTRALIA TRANSPLANTATION MARKET SIZE, BY ORGAN FAILURE TREATMENT, 2018-2030 (USD MILLION)
TABLE 313. AUSTRALIA TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 314. AUSTRALIA TRANSPLANTATION MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 315. AUSTRALIA TRANSPLANTATION MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 316. AUSTRALIA TRANSPLANTATION MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 317. AUSTRALIA TRANSPLANTATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 318. AUSTRALIA TRANSPLANTATION MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
TABLE 319. AUSTRALIA TRANSPLANTATION MARKET SIZE, BY OPEN SURGERY, 2018-2030 (USD MILLION)
TABLE 320. AUSTRALIA TRANSPLANTATION MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 321. AUSTRALIA TRANSPLANTATION MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 322. AUSTRALIA TRANSPLANTATION MARKET SIZE, BY SYNTHETICS, 2018-2030 (USD MILLION)
TABLE 323. CHINA TRANSPLANTATION MARKET SIZE, BY ORGAN TYPE, 2018-2030 (USD MILLION)
TABLE 324. CHINA TRANSPLANTATION MARKET SIZE, BY HEART, 2018-2030 (USD MILLION)
TABLE 325. CHINA TRANSPLANTATION MARKET SIZE, BY INTESTINE, 2018-2030 (USD MILLION)
TABLE 326. CHINA TRANSPLANTATION MARKET SIZE, BY KIDNEY, 2018-2030 (USD MILLION)
TABLE 327. CHINA TRANSPLANTATION MARKET SIZE, BY LIVER, 2018-2030 (USD MILLION)
TABLE 328. CHINA TRANSPLANTATION MARKET SIZE, BY LUNG, 2018-2030 (USD MILLION)
TABLE 329. CHINA TRANSPLANTATION MARKET SIZE, BY PANCREAS, 2018-2030 (USD MILLION)
TABLE 330. CHINA TRANSPLANTATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
TABLE 331. CHINA TRANSPLANTATION MARKET SIZE, BY TRANSPLANTATION TYPE, 2018-2030 (USD MILLION)
TABLE 332. CHINA TRANSPLANTATION MARKET SIZE, BY ALLOGRAFT, 2018-2030 (USD MILLION)
TABLE 333. CHINA TRANSPLANTATION MARKET SIZE, BY AUTOGRAFT, 2018-2030 (USD MILLION)
TABLE 334. CHINA TRANSPLANTATION MARKET SIZE, BY ISOGRAFT, 2018-2030 (USD MILLION)
TABLE 335. CHINA TRANSPLANTATION MARKET SIZE, BY XENOGRAFT, 2018-2030 (USD MILLION)
TABLE 336. CHINA TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 337. CHINA TRANSPLANTATION MARKET SIZE, BY CANCER TREATMENT, 2018-2030 (USD MILLION)
TABLE 338. CHINA TRANSPLANTATION MARKET SIZE, BY CORRECTION OF CONGENITAL DEFECTS, 2018-2030 (USD MILLION)
TABLE 339. CHINA TRANSPLANTATION MARKET SIZE, BY COSMETIC ENHANCEMENT, 2018-2030 (USD MILLION)
TABLE 340. CHINA TRANSPLANTATION MARKET SIZE, BY ORGAN FAILURE TREATMENT, 2018-2030 (USD MILLION)
TABLE 341. CHINA TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 342. CHINA TRANSPLANTATION MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 343. CHINA TRANSPLANTATION MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 344. CHINA TRANSPLANTATION MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 345. CHINA TRANSPLANTATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 346. CHINA TRANSPLANTATION MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
TABLE 347. CHINA TRANSPLANTATION MARKET SIZE, BY OPEN SURGERY, 2018-2030 (USD MILLION)
TABLE 348. CHINA TRANSPLANTATION MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 349. CHINA TRANSPLANTATION MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 350. CHINA TRANSPLANTATION MARKET SIZE, BY SYNTHETICS, 2018-2030 (USD MILLION)
TABLE 351. INDIA TRANSPLANTATION MARKET SIZE, BY ORGAN TYPE, 2018-2030 (USD MILLION)
TABLE 352. INDIA TRANSPLANTATION MARKET SIZE, BY HEART, 2018-2030 (USD MILLION)
TABLE 353. INDIA TRANSPLANTATION MARKET SIZE, BY INTESTINE, 2018-2030 (USD MILLION)
TABLE 354. INDIA TRANSPLANTATION MARKET SIZE, BY KIDNEY, 2018-2030 (USD MILLION)
TABLE 355. INDIA TRANSPLANTATION MARKET SIZE, BY LIVER, 2018-2030 (USD MILLION)
TABLE 356. INDIA TRANSPLANTATION MARKET SIZE, BY LUNG, 2018-2030 (USD MILLION)
TABLE 357. INDIA TRANSPLANTATION MARKET SIZE, BY PANCREAS, 2018-2030 (USD MILLION)
TABLE 358. INDIA TRANSPLANTATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
TABLE 359. INDIA TRANSPLANTATION MARKET SIZE, BY TRANSPLANTATION TYPE, 2018-2030 (USD MILLION)
TABLE 360. INDIA TRANSPLANTATION MARKET SIZE, BY ALLOGRAFT, 2018-2030 (USD MILLION)
TABLE 361. INDIA TRANSP

Companies Mentioned

  • AbbVie Inc.
  • Arthrex, Inc.
  • Australian Red Cross Lifeblood
  • BioLife Solutions Inc.
  • Dr. Franz Kohler Chemie GmbH
  • LifeCell International Pvt. Ltd.
  • Mid-America Transplant
  • Novartis AG
  • Sanofi S.A.
  • Stryker Corporation
  • Terumo Corporation
  • Teva Pharmaceutical Industries Ltd
  • TransMedics, Inc.
  • Veloxis Pharmaceuticals
  • Zimmer Biomet

Methodology

Loading
LOADING...

Related Topics

Related Reports

Organ Transplantation Market by Type of Organ (Heart Transplantation, Kidney Transplantation, Liver Transplantation), Product Type (Immunosuppressive Drugs, Organ Perfusion Systems, Preservation Solutions), Source of Organs, End-User - Global Forecast 2025-2030 - Product Image

Organ Transplantation Market by Type of Organ (Heart Transplantation, Kidney Transplantation, Liver Transplantation), Product Type (Immunosuppressive Drugs, Organ Perfusion Systems, Preservation Solutions), Source of Organs, End-User - Global Forecast 2025-2030

  • Report
  • 185 Pages
  • Global
From
Solid Organ Transplantation Rejection Market by Rejection Type (Acute Rejection, Chronic Rejection, Hyperacute Rejection), Offering (Diagnosis & Testing Solutions, Medications), Type Of Organ Transplant, End User - Global Forecast 2025-2030 - Product Image

Solid Organ Transplantation Rejection Market by Rejection Type (Acute Rejection, Chronic Rejection, Hyperacute Rejection), Offering (Diagnosis & Testing Solutions, Medications), Type Of Organ Transplant, End User - Global Forecast 2025-2030

  • Report
  • 185 Pages
  • Global
From
Heart Transplantation Therapeutics Market Size, Share & Trends Analysis Report By Drug Type (Immunosuppressants, Anti-infectives, Analgesics), By Distribution Channel (Hospital Pharmacies), By Region, And Segment Forecasts, 2024 - 2030 - Product Image

Heart Transplantation Therapeutics Market Size, Share & Trends Analysis Report By Drug Type (Immunosuppressants, Anti-infectives, Analgesics), By Distribution Channel (Hospital Pharmacies), By Region, And Segment Forecasts, 2024 - 2030

  • Report
  • 120 Pages
  • Global
From
Organ Transplant Immunosuppressant Drugs - Global Strategic Business Report - Product Image

Organ Transplant Immunosuppressant Drugs - Global Strategic Business Report

  • Report
  • 196 Pages
  • Global
From
Transplantation Market by Product, Application, End User, and Region 2025-2033 - Product Image

Transplantation Market by Product, Application, End User, and Region 2025-2033

  • Report
  • 123 Pages
  • Global
From

About the Transplantation Market

The Transplantation market within the context of Biotechnology is focused on the development of treatments and technologies that enable the successful transfer of organs, tissues, and cells from one individual to another. This includes the development of new methods for organ preservation, the development of new immunosuppressive drugs, and the development of new technologies for organ matching. Additionally, the market is focused on the development of new methods for organ harvesting, as well as the development of new methods for organ transplantation. The Transplantation market is a rapidly growing sector of the biotechnology industry, with many companies investing in research and development to improve the success rate of organ transplants. Companies in this market include Organogenesis, Organovo, Histogenics, and United Therapeutics. Additionally, many pharmaceutical companies are investing in the development of new immunosuppressive drugs to improve the success rate of organ transplants. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.